Skip to content

News

Neurotherapeutics wins Medilink Midlands ‘one to watch‘ award

Neurotherapeutics wins Medilink Midlands ‘one to watch‘ award

At an awards night on 27th Jan 2022 Neurotherapeutics won the ‘One to watch’ award. Professor Stephen and Georgina Jackson attended the awards ceremony and accepted the award. Stephen Jackson said that this award confirms the very real potential of the approach we are taking at Neurotherpeutics Ltd to reduce tics and change individuals lives with tic disorders like Tourette syndrome

Learn more
Professor Stephen Jackson appointed Chair of the Scientific Advisory Board for the Federation of European Societies for Neuropsychology (FESN)

Professor Stephen Jackson appointed Chair of the Scientific Advisory Board for the Federation of European Societies for Neuropsychology (FESN)

Professor Stephen Jackson was Recently appointed Chair of the Scientific Advisory Board for the Federation of European Societies for Neuropsychology (FESN).

Learn more
MHRA Approval for use of Clinical investigation devices

MHRA Approval for use of Clinical investigation devices

Neurotherapeutics Ltd received MHRA approval to use prototype clinical investigation devices in a new clinical study which will start in March 2022. This study will investigate the impact of median nerve stimulation on reducing tics in individuals with Tourette syndrome.

Learn more
Neurotherapeutics Ltd listed as finalists in Medilink East Midlands Awards

Neurotherapeutics Ltd listed as finalists in Medilink East Midlands Awards

Neurotherapeutics Ltd has been shortlisted as a finalist for the Medilink Midlands Business Awards 2022 in 3 categories: ONE TO WATCH - Awarded to a business that shows a great deal of potential START UP - Awarded to a newly established business which demonstrates exceptional promise for the future PARTNERSHIP BETWEEN ACADEMIA AND BUSINESS - Awarded to the company who demonstrate how the collaboration / partnership has or will enhance current service delivery or create new ways of delivering healthcare. Neurotherapeutics Ltd  has been shortlisted for these prestigious awards which recognises and promotes the excellence that East and West Midlands companies are achieving at the leading edge of the Life Sciences sector. The 2022 awards will take place in person and will be the first opportunity since the merger of the East and West Midlands Medilink regions for members and the Life Sciences community to gather together to celebrate and network. 50 entries submitted across the 8 categories will be assessed by a panel of experts from the Life Science sector to select the winners. A winner will be announced for both the East and West Midlands Regions.

Learn more